What is the 13F Pro Quality Score for ITGR?

13F Pro ranks Integer Holdings Corp (ITGR) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ITGR's current score at https://13fpro.ai/company/ITGR (free sign-up required for the full ranking).

Which hedge funds own the most ITGR stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of ITGR include BlackRock,, Invesco Ltd., VANGUARD PORTFOLIO MANAGEMENT. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/ITGR as soon as new 13F filings post.

Where does 13F Pro source ITGR data?

All Integer Holdings Corp fundamentals and ownership data come directly from SEC EDGAR. Integer Holdings Corp files with the SEC under CIK 1114483. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ITGR in?

Integer Holdings Corp (ITGR) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives ITGR's revenue?

Per Integer Holdings Corp's latest 10-Q filed with the SEC on 2026-08-04, the biggest revenue drivers are: Cardio & Vascular ($280.3M, -2.3% YoY); Cardiac Rhythm Management & Neuromodulation ($173.7M, +1.0% YoY); Other Markets ($10.1M, -42.8% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/ITGR.

What are ITGR's largest expenses?

Integer Holdings Corp's latest 10-Q reports these as the largest expense items: Cost of sales ($351.2M, +1.1% YoY); Selling, general and administrative ($57.7M, +9.0% YoY); Restructuring and other charges ($9.4M, +256.0% YoY). Sourced directly from SEC EDGAR filing text for Q2 FY2026 (quarter ended July 3, 2026).

How often is ITGR research updated on 13F Pro?

ITGR's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Integer Holdings Corp(ITGR)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSEmid

Institutional-grade research for retail investors

SEC EDGAR: CIK 1114483 ITGR stock profile & AI dashboard →

13F Pro Quality Score

55.9/100

Rank #1,217 of 2,961 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

47.6/100

Profitability

61.2/100

Balance Sheet

64.1/100

Earnings Quality

76.7/100

Free Cash Flow

45.4/100

Institutional Flow

25.6/100

Revenue Scale

61.6/100

Dilution Risk

51.0/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why ITGR Scores 56/100

exact factor attribution · 2026-09-11

ITGR's composite is driven by earnings quality and scale, held back by institutional flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings quality

+2.7 pts

77th pct

Scale

+1.7 pts

62th pct

Profitability

+1.7 pts

61th pct

Capital efficiency

+1.4 pts

64th pct

Earnings growth

+0.7 pts

64th pct

Shareholder dilution

+0.1 pts

51th pct

Revenue growth

-0.5 pts

48th pct

Free cash flow

-0.7 pts

45th pct

Institutional flow

-1.2 pts

26th pct

Latest change (2026-08-04): 50 → 56 · ↑ Profit margin 40→66; ↑ Capital efficiency 52→62; despite ↓ Revenue growth 60→45

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

ITGR Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Integer Holdings Corp (ITGR), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ITGR at 55.9/100 on a 32-signal composite quality model, placing it at rank #1,217 of 2,961 stocks — the top half of the AI-ranked universe. ITGR scores in the top quartile across earnings quality (76.7). Areas of concern include institutional flow (25.6), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Integer Holdings Corp reports quarterly revenue of $464.1M, net income of $23.6M, an operating margin of 7.4%. Top institutional holders of ITGR by reported 13-F value include BlackRock, Invesco Ltd., VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. ITGR trades on the NYSE exchange and files with the SEC under CIK 1114483. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ITGR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Integer Holdings Corp directly from SEC EDGAR. Integer Holdings Corp's 13F Pro composite quality score has ranged between 40 and 64 since 2021, currently 55.9 — an improving long-term trajectory across 68 quarterly and live scoring snapshots.

✦

Fun facts about Integer Holdings Corp

Quirks, history, and lore behind ITGR — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. medical device company · mid-cap · listed on NYSE · headquartered in Texas.
2
The Numbers
Annual revenue in the range of $1.5 billion, with operations spanning roughly 30 countries — a global footprint that belies its under-the-radar profile.
3
The History
Traces its roots to a cardiac rhythm management supplier founded in the 1970s, eventually growing through acquisitions into a broad implantable device manufacturer.
4
The Secret
It doesn't make the flashy gadgets — it makes the components inside them: batteries, capacitors, and precision parts that other medtech giants quietly buy and build into their own branded devices.
5
The Lore
Its customers include virtually every major cardiac and neuromodulation device maker on the planet, meaning its parts may already be ticking away inside millions of patients right now.
6
The Giveaway
Its ticker is a math word, its name is a math word, but its specialty is the implantable medical components — batteries, leads, and enclosures — powering pacemakers and neurostimulators worldwide.

▶ Think you know your stocks? Play the Daily Ticker

What's Driving ITGR's Business? Latest 10-Q Breakdown

AI-extracted from Integer Holdings Corp's 10-Q filed 2026-08-04 — Q2 FY2026 (quarter ended July 3, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Integer Holdings reported Q2 2026 revenue of $464.1M, down 2.6% YoY, with operating income declining 41.8% to $34.5M due to lower fixed cost absorption and three new products underperforming market adoption expectations.

Biggest Revenue Drivers

Cardio & Vascular$280.3M-2.3% YoY

Lower sales of two new Electrophysiology products due to lower than anticipated market adoption, partially offset by 2025 acquisitions.

Cardiac Rhythm Management & Neuromodulation$173.7M+1.0% YoY

Growth partially offset by lower sales of a Neuromodulation product due to lower than anticipated market adoption.

Biggest Revenue Drivers

Total revenue: $464.1M-2.6% YoY

Cardio & Vascular$280.3M-2.3% YoY

Lower sales of two new Electrophysiology products due to lower than anticipated market adoption, partially offset by 2025 acquisitions.

Cardiac Rhythm Management & Neuromodulation$173.7M+1.0% YoY

Growth partially offset by lower sales of a Neuromodulation product due to lower than anticipated market adoption.

Other Markets$10.1M-42.8% YoY

Decline primarily due to the Portable Medical Exit.

Largest Expense Items

Cost of sales$351.2M+1.1% YoY

Increased primarily due to lower fixed cost absorption from lower production volumes.

Selling, general and administrative$57.7M+9.0% YoY

Higher professional fees for stockholder activist matter and securities class action lawsuit defense; higher contract services for IT enhancements.

Restructuring and other charges$9.4M+256.0% YoY

$5.9M fixed asset impairment from revised expectations on future use of certain assets; higher restructuring charges.

Research, development and engineering$11.3M-20.8% YoY

Decrease primarily due to timing of program milestone achievements for customer funded programs.

Watch Items from the Filing

Three significant new products experienced lower than anticipated market adoption in Q2 2026, impacting sales and requiring reassessment of growth strategy.
Customer concentration: Customer A represents 18%, Customer B 17%, and Customer C 17% of Q2 2026 revenue; top three customers represent 52% of sales.
On August 2, 2026, Integer agreed to be acquired by KKR affiliates for $127 per share; pending stockholder approval and regulatory clearance with outside date of May 2, 2027.
Fixed asset impairment charge of $5.9M in Q2 2026 reflects revised expectations on future use of manufacturing equipment and reduced recovery confidence.
Gross margin pressure continues; company expects gross margin to fluctuate but has not provided recovery timeline for the 280 bps decline.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$464.1M

Net Income

Q2 2026

$23.6M

Free Cash Flow

Q2 2026

$37.0M

Operating Margin

Q2 2026

7.4%

ROIC

Q2 2026

4.7%

D/E Ratio

Q2 2026

0.72

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+8.0% YoY

$1.85BFY 2025

FY22 $1.33BFY23 $1.56BFY24 $1.72BFY25 $1.85B

Net Income

-14.3% YoY

$102.8MFY 2025

FY22 $66.4MFY23 $90.7MFY24 $119.9MFY25 $102.8M

Operating Income

+6.3% YoY

$221.3MFY 2025

FY22 $112.7MFY23 $163.3MFY24 $208.2MFY25 $221.3M

EPS (Diluted)

-14.0% YoY

$2.89FY 2025

FY22 $1.99FY23 $2.69FY24 $3.36FY25 $2.89

Total Assets

+10.8% YoY

$3.41BFY 2025

FY22 $2.79BFY23 $2.94BFY24 $3.08BFY25 $3.41B

Total Debt

+18.5% YoY

$1.19BFY 2025

FY22 $943.4MFY23 $959.9MFY24 $1.00BFY25 $1.19B

Op. Cash Flow

-4.4% YoY

$196.1MFY 2025

FY22 $116.4MFY23 $180.2MFY24 $205.2MFY25 $196.1M

Free Cash Flow

+5.3% YoY

$105.1MFY 2025

FY22 $41.7MFY23 $60.3MFY24 $99.8MFY25 $105.1M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$1.85B +8.0%	$1.72B +10.3%	$1.56B +16.9%	$1.33B +9.0%	$1.22B +13.8%	$1.07B
Net Income	$102.8M -14.3%	$119.9M +32.3%	$90.7M +36.6%	$66.4M -31.4%	$96.8M +25.3%	$77.3M
Operating Income	$221.3M +6.3%	$208.2M +27.5%	$163.3M +44.9%	$112.7M -17.0%	$135.7M +12.5%	$120.6M
EPS (Diluted)	$2.89 -14.0%	$3.36 +24.9%	$2.69 +35.2%	$1.99 -31.6%	$2.91 +24.9%	$2.33
Total Assets	$3.41B +10.8%	$3.08B +4.6%	$2.94B +5.3%	$2.79B +8.2%	$2.58B +8.9%	$2.37B
Total Debt	$1.19B +18.5%	$1.00B +4.2%	$959.9M +1.7%	$943.4M +11.9%	$843.4M +9.7%	$768.8M
Operating Cash Flow	$196.1M -4.4%	$205.2M +13.9%	$180.2M +54.8%	$116.4M -25.7%	$156.7M -13.6%	$181.3M
Free Cash Flow	$105.1M +5.3%	$99.8M +65.7%	$60.3M +44.7%	$41.7M -59.6%	$103.2M -23.3%	$134.5M

Get alerted when ITGR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Integer Holdings Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ITGR

BlackRock, Inc.
$500.3M5,353,741 sh
Invesco Ltd.
$210.0M2,247,031 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$190.7M2,040,469 sh
DIMENSIONAL FUND ADVISORS LP
$152.1M1,627,784 sh
NOMURA HOLDINGS INC
$145.3M1,554,450 sh
VANGUARD CAPITAL MANAGEMENT LLC
$143.2M1,531,843 sh
STATE STREET CORP
$132.0M1,413,174 sh
MORGAN STANLEY
$125.8M1,345,748 sh
Irenic Capital Management LP
$118.1M1,264,259 sh
EARNEST PARTNERS LLC
$94.2M1,008,519 sh

Fund	Value	Shares
BlackRock, Inc.	$500.3M	5,353,741
Invesco Ltd.	$210.0M	2,247,031
VANGUARD PORTFOLIO MANAGEMENT LLC	$190.7M	2,040,469
DIMENSIONAL FUND ADVISORS LP	$152.1M	1,627,784
NOMURA HOLDINGS INC	$145.3M	1,554,450
VANGUARD CAPITAL MANAGEMENT LLC	$143.2M	1,531,843
STATE STREET CORP	$132.0M	1,413,174
MORGAN STANLEY	$125.8M	1,345,748
Irenic Capital Management LP	$118.1M	1,264,259
EARNEST PARTNERS LLC	$94.2M	1,008,519

Companies Similar to ITGR

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

EYE

National Vision Holdings, Inc.

AI score

Similar quality profile · 9 shared holders

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC RE ADVISERS CORP Boston Partners

PBH

Prestige Consumer Healthcare Inc.

AI score

Similar quality profile · 16 shared holders

SILVERCREST ASSET MANAGEMENT GROUP LLC FULLER & THALER ASSET MANAGEMENT, INC.ARMISTICE CAPITAL, LLC

CNMD

CONMED Corp

AI score

Similar quality profile · 14 shared holders

EARNEST PARTNERS LLC COOKE & BIELER LP FULLER & THALER ASSET MANAGEMENT, INC.

NVST

Envista Holdings Corp

AI score

Similar quality profile · 9 shared holders

FULLER & THALER ASSET MANAGEMENT, INC.PALISADE CAPITAL MANAGEMENT, LP HEARTLAND ADVISORS INC

AMRX

Amneal Pharmaceuticals, Inc.

AI score

Similar quality profile · 4 shared holders

Nantahala Capital Management, LLC PFM Health Sciences, LP KENNEDY CAPITAL MANAGEMENT LLC

BFAM

BRIGHT HORIZONS FAMILY SOLUTIONS INC.

AI score

Similar quality profile · 11 shared holders

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC FULLER & THALER ASSET MANAGEMENT, INC.PALISADE CAPITAL MANAGEMENT, LP

IART

INTEGRA LIFESCIENCES HOLDINGS CORP

AI score

Similar quality profile · 6 shared holders

FULLER & THALER ASSET MANAGEMENT, INC.PFM Health Sciences, LP New Age Alpha Advisors, LLC

CON

Concentra Group Holdings Parent, Inc.

AI score

Similar quality profile · 13 shared holders

HBK INVESTMENTS L P Tributary Capital Management, LLC Dana Investment Advisors, Inc.

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ITGR on your watchlist

Track score changes the day Integer Holdings Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ITGR a good stock to buy?

13F Pro's AI-powered analysis of Integer Holdings Corp (ITGR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ITGR are available on the ITGR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ITGR is classified as a mid company.

Which hedge funds own ITGR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ITGR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Integer Holdings Corp's investment landscape.